Related Experiment Videos
Genetic studies in Borrelia burgdorferi
1Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA. patricia_rosa@nih.gov
Wiener Klinische Wochenschrift
|February 27, 1999
Summary
Researchers are developing genetic tools to study Lyme disease pathogenesis by inactivating genes in Borrelia burgdorferi. This work aims to understand how specific bacterial components contribute to the infectious cycle and disease development.
Area of Science:
- Microbiology
- Genetics
- Pathogenesis
Background:
- Genomic sequencing of Borrelia burgdorferi (Lyme disease agent) is complete, but its pathogenesis and life cycle functions remain poorly understood.
- A lack of robust genetic systems in B. burgdorferi hinders research due to its unique biology compared to other bacteria.
Purpose of the Study:
- To develop and improve genetic tools for manipulating Borrelia burgdorferi.
- To investigate the roles of specific plasmid-encoded gene products in B. burgdorferi pathogenesis and its life cycle.
- To utilize an animal model for studying Lyme disease transmission.
Main Methods:
- Targeted gene inactivation via allelic exchange using coumermycin-resistant topoisomerase (gyrBr) as a selectable marker.
- Electroporation for transforming B. burgdorferi spirochetes.
- Polymerase Chain Reaction (PCR) for screening gene inactivation events.
Main Results:
- Successfully demonstrated targeted gene inactivation in the B. burgdorferi type strain B31.
- Inactivated several genes of interest using the gyrBr selectable marker.
- Exploring additional antibiotic resistance genes as selectable markers.
Conclusions:
- Targeted gene inactivation is crucial for understanding bacterial biology and virulence.
- Significant progress has been made in genetically manipulating B. burgdorferi.
- Ongoing efforts focus on refining existing methods and developing new genetic tools for B. burgdorferi research.